1
|
Starcevic V. Representation of Benzodiazepines in Treatment Guidelines: The Paradox of Undesirable Objectivity. PSYCHOTHERAPY AND PSYCHOSOMATICS 2022; 91:295-299. [PMID: 35551128 DOI: 10.1159/000524772] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Accepted: 04/26/2022] [Indexed: 11/19/2022]
Affiliation(s)
- Vladan Starcevic
- Faculty of Medicine and Health, Sydney Medical School, Nepean Clinical School, Specialty of Psychiatry, University of Sydney, Sydney, New South Wales, Australia.,Nepean Hospital, Department of Psychiatry, Penrith, New South Wales, Australia
| |
Collapse
|
2
|
Understanding the Life, Pain, and Barriers to Physical Activity in Korean Patients with Panic Disorder: Photovoice Inquiry. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph18158140. [PMID: 34360432 PMCID: PMC8346144 DOI: 10.3390/ijerph18158140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Revised: 07/22/2021] [Accepted: 07/29/2021] [Indexed: 11/29/2022]
Abstract
Purpose: This study attempted to understand the life, pain, and barriers to physical activity in the daily life of patients with panic disorder (PD). It aimed to provide specific evidence to promote physical activity for patients, suggesting that suitable physical activity strategies for patients with PD would be of value. Methods: Seven patients were invited to participate in a photovoice study. Photovoice is one example of participatory action research. Results: This study inductively identified two main themes: the life and pain of patients with PD and perceived barriers to participate in physical activity by patients with panic disorder. Conclusion: Based on a specific understanding of the population, this study attempted to provide evidence why patients with panic disorder need appropriate physical-activity-promoting strategies.
Collapse
|
3
|
Maltsev DV, Spasov AA, Yakovlev DS, Vassiliev PM, Skripka MO, Miroshnikov MV, Sultanova KT, Kochetkov AN, Divaeva LN, Kuzmenko TA, Morkovnik AS. Searching for new anxiolytic agents among derivatives of 11-dialkylaminoethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazole. Eur J Pharm Sci 2021; 161:105792. [PMID: 33705965 DOI: 10.1016/j.ejps.2021.105792] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2020] [Revised: 02/27/2021] [Accepted: 03/03/2021] [Indexed: 12/14/2022]
Abstract
A study on the anxiolytic activity of the new derivatives of 11-dialkylaminoethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazole, containing privileged scaffolds of benzodiazepine and benzimidazole in their structure, was conducted. The cytotoxic properties of low levels of six compounds were preliminary determined in vitro using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide test. The screening of these substances for anxiolytic activity was conducted using elevated plus maze (EPM) test in vivo, and DAB-21 was found to be the most active compound. The acute toxicity of DAB-21 was determined as less toxic than that of diazepam. The dose-dependent effect of the most active compound revealed a minimum dose of 1.26 mg/kg, which resulted in the maximum counterphobic effect. The effect of DAB-21 was superior in a number of tests compared with that of diazepam, which indicated a high level of tranquilizing activity for DAB-21. The results of in silico docking analysis suggest that DAB-21 should have a slightly lower anxiolytic activity than diazepam, but should exhibit greater specific affinity for the benzodiazepine site of the GABAA receptor, in comparison with its GABA-binding site. The interaction between DAB-21 and flumazenil in terms of EPM verifies the GABAergic mechanism of action of DAB-21. Our results highlight the potential of 11-dialkylaminomethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazoles as promising compounds in the search for new highly effective anxiolytics.
Collapse
Affiliation(s)
- Dmitriy V Maltsev
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia; Volgograd Medical Research Center; 1 Pavshikh Bortsov sq., Volgograd, Russia.
| | - Alexander A Spasov
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia; Volgograd Medical Research Center; 1 Pavshikh Bortsov sq., Volgograd, Russia
| | - Dmitriy S Yakovlev
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia; Volgograd Medical Research Center; 1 Pavshikh Bortsov sq., Volgograd, Russia
| | - Pavel M Vassiliev
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia
| | - Maria O Skripka
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia
| | - Mikhail V Miroshnikov
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia
| | - Kira T Sultanova
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia; Volgograd Medical Research Center; 1 Pavshikh Bortsov sq., Volgograd, Russia
| | - Andrey N Kochetkov
- Volgograd State Medical University, Department of Pharmacology and Bioinformatics; 1 Pavshikh Bortsov sq., Volgograd, Russia
| | - Lyudmila N Divaeva
- Southern Federal University, Research Institute of Physical and Organic Chemistry; 105/42 Bolshaya Sadovaya str., Rostov-on-Don, Russia
| | - Tatyana A Kuzmenko
- Southern Federal University, Research Institute of Physical and Organic Chemistry; 105/42 Bolshaya Sadovaya str., Rostov-on-Don, Russia
| | - Anatolii S Morkovnik
- Southern Federal University, Research Institute of Physical and Organic Chemistry; 105/42 Bolshaya Sadovaya str., Rostov-on-Don, Russia
| |
Collapse
|
5
|
De Carlo V, Grancini B, Vismara M, Benatti B, Arici C, Cremaschi L, Cirnigliaro G, Degoni L, Oldani L, Palazzo C, Glick ID, Viganò C, Dell'Osso B. Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses. Hum Psychopharmacol 2019; 34:e2695. [PMID: 31044486 DOI: 10.1002/hup.2695] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2018] [Revised: 03/07/2019] [Accepted: 03/13/2019] [Indexed: 12/20/2022]
Abstract
OBJECTIVE In patients with affective disorders, benzodiazepines (BZDs) are frequently administered at the onset, sometimes inappropriately. We sought to identify clinical variables associated with first BZD prescription in a large sample of patients with affective disorders. METHODS Four hundred sixty patients with mood or anxiety disorders attending different psychiatric services were assessed comparing those who received BZD as first treatment (BZD w/) and those who did not (BZD w/o). RESULTS More than one third (35.7%) of the total sample had received BZDs as first prescription. In relation to mood disorders, BZD w/ subjects more frequently (a) had not a psychiatrist as first therapist, (b) had anxious symptoms at onset, (c) had adjustment disorder as first diagnosis, (d) were treated as outpatients. In relation to specific diagnoses, (a) personal decision of treatment for major depressive disorder, (b) outpatient status for bipolar disorder and (c) longer duration of untreated illness for adjustment disorder were more frequently associated with first BZD prescription. For anxiety disorders, the presence of stressful life events and the diagnoses of panic disorder or specific phobias were more frequently observed in BZD w/ patients. CONCLUSION Patients with affective disorders frequently received BZDs as first prescription with significant differences between and within mood and anxiety disorders.
Collapse
Affiliation(s)
- Vera De Carlo
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Benedetta Grancini
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Matteo Vismara
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Beatrice Benatti
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Chiara Arici
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Laura Cremaschi
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Giovanna Cirnigliaro
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Luca Degoni
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Lucio Oldani
- Department of Mental Health, Fondazione IRCCS Cà Granda Policlinico, Milan, Italy
| | - Carlotta Palazzo
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Ira D Glick
- Department of Psychiatry and Behavioural Sciences, Stanford Medical School, Stanford University, Stanford, California
| | - Caterina Viganò
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy
| | - Bernardo Dell'Osso
- Department of Biomedical and Clinical Sciences "Luigi Sacco," Psychiatry Unit, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy.,Department of Psychiatry and Behavioural Sciences, Stanford Medical School, Stanford University, Stanford, California.,CRC "Aldo Ravelli" for Neurotechnology and Experimental Brain Therapeutics, University of Milan, Milan, Italy
| |
Collapse
|